Navigation path

Pharmaceuticals - Union Register


Register of not active orphan medicinal products


Product information

Yttrium (90Y) edotreotide

EU orphan designation number: EU/3/08/589
Active ingredient: Yttrium (90Y) edotreotide
Indication: Treatment of gastro-entero-pancreatic neuroendocrine tumours
Sponsor: Molecular Insight Limited
Eversheds House, 70 Great Bridgewater Street, Manchester, M1 5ES, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
9/12/2008 Orphan designation EMEA/OD/057/08 (2008)8167 of 4/12/2008
8/06/2010 Transfer of orphan designation EMEA/OD/057/08/T/01 (2010)3714 of 4/06/2010
2/08/2013 Transfer of orphan designation EMEA/OD/057/08/T/02 (2013)5101 of 31/07/2013
19/01/2016 Transfer of orphan designation EMA/OD/057/08/T/03 (2016)253 of 15/01/2016
23/04/2018 Removal of orphan designation from Community Register